| Medical and Health Sciences | Lifetime | 129 | US 73 | 99.99 |
| Surgery | Lifetime | 15 | US 6 | 99.98 |
| Transplantation | Lifetime | 1 | US 1 | 99.95 |
| Hepatology | Lifetime | 20 | US 10 | 99.84 |
| Epidemiology | Lifetime | 259 | US 131 | 99.68 |
| Public, Environmental and Occupational Health | Lifetime | 278 | US 133 | 99.61 |
| Oncology | Lifetime | 610 | US 336 | 98.82 |
| Immunology | Lifetime | 577 | US 292 | 98.27 |
| Clinical Biochemistry | Lifetime | 185 | US 90 | 96.77 |
| Nutrition and Dietetics | Lifetime | 672 | US 273 | 96.93 |
| Hematology | Lifetime | 643 | US 327 | 94.80 |
| Organ Transplantation Techniques and Outcomes | Lifetime | 1 | US 1 | 99.98 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 1 | US 1 | 99.97 |
| Organ Donation and Transplantation | Lifetime | 1 | US 1 | 99.94 |
| Liver Disease and Transplantation | Lifetime | 5 | US 3 | 99.96 |
| Organ and Tissue Transplantation Research | Lifetime | 1 | US 1 | 99.93 |
| Transplantation: Methods and Outcomes | Lifetime | 10 | US 8 | 99.79 |
| Xenotransplantation and immune response | Lifetime | 1 | US 1 | 99.76 |
| Liver Disease Diagnosis and Treatment | Lifetime | 72 | US 26 | 99.85 |
| Liver physiology and pathology | Lifetime | 15 | US 6 | 99.74 |
| Congenital Anomalies and Fetal Surgery | Lifetime | 24 | US 13 | 99.58 |
| Polyomavirus and related diseases | Lifetime | 24 | US 9 | 99.52 |
| Signaling Pathways in Disease | Lifetime | 25 | US 19 | 99.47 |
| Renal and Vascular Pathologies | Lifetime | 44 | US 31 | 99.52 |
| Metabolism and Genetic Disorders | Lifetime | 108 | US 51 | 99.37 |
| Cytomegalovirus and herpesvirus research | Lifetime | 75 | US 51 | 99.37 |
| Clinical Nutrition and Gastroenterology | Lifetime | 48 | US 24 | 99.34 |
| Pediatric Hepatobiliary Diseases and Treatments | Lifetime | 92 | US 42 | 99.25 |
| Neurological Complications and Syndromes | Lifetime | 38 | US 19 | 98.97 |
| Blood groups and transfusion | Lifetime | 121 | US 54 | 98.73 |
| Pancreatic function and diabetes | Lifetime | 304 | US 140 | 99.01 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 182 | US 78 | 98.88 |
| Viral-associated cancers and disorders | Lifetime | 164 | US 80 | 98.90 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 310 | US 96 | 98.91 |
| T-cell and B-cell Immunology | Lifetime | 733 | US 374 | 98.70 |
| Liver Diseases and Immunity | Lifetime | 207 | US 63 | 98.24 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 540 | US 273 | 97.95 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 713 | US 198 | 97.39 |
| Drug-Induced Hepatotoxicity and Protection | Lifetime | 635 | US 214 | 95.81 |
| Abdominal Trauma and Injuries | Lifetime | 395 | US 236 | 95.18 |
| Neonatal Health and Biochemistry | Lifetime | 934 | US 449 | 94.71 |
| Genetic and Kidney Cyst Diseases | Lifetime | 601 | US 265 | 93.24 |
| Complement system in diseases | Lifetime | 782 | US 301 | 94.16 |
| Pregnancy and Medication Impact | Lifetime | 879 | US 336 | 92.57 |
| Parvovirus B19 Infection Studies | Lifetime | 960 | US 401 | 91.83 |
| Vascular Tumors and Angiosarcomas | Lifetime | 954 | US 424 | 89.87 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 938 | US 289 | 87.66 |
| Medical History and Research | Lifetime | 503 | US 166 | 80.48 |
